Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Pyrazinamide")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 575

  • Page / 23
Export

Selection :

  • and

Automated Chemiluminometric Screening of Counterfeit Drugs of the Antituberculosis Agent PyrazinamidePRIOR, Joao A. V; SANTOS, Joao L. M; LIMA, José L. F. C et al.Journal of AOAC International. 2009, Vol 92, Num 3, pp 830-836, issn 1060-3271, 7 p.Article

Pyrazinamide-induced sideroblastic anemiaCOLUCCI, Giuseppe; SILZLE, Tobias; SOLENTHALER, Max et al.American journal of hematology. 2012, Vol 87, Num 3, issn 0361-8609, p. 305Article

Iron enhances the antituberculous activity of pyrazinamideSOMOSKOVI, Akos; WADE, Mary Margaret; ZHONGHE SUN et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 2, pp 192-196, issn 0305-7453, 5 p.Article

METABOLISM OF PYRAZINAMIDE. PYRAZINAMIDE DEAMIDASE OF ANIMAL TISSUESTOIDA I.1973; AMER. REV. RESP. DIS.; U.S.A.; DA. 1973; VOL. 107; NO 4; PP. 630-638; BIBL. 19 REF.Serial Issue

Réaction cutanée après une prise de pyrazinamide = Cutaneous reaction after pyrazinamide initiationMULLIEZ, P; MBASSI FOUDA, F.-L; ROY SAINT-GEORGES, F et al.Médecine et maladies infectieuses. 2011, Vol 41, Num 9, pp 499-500, issn 0399-077X, 2 p.Article

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosisPIERRE-AUDIGIER, C; SURCOUF, C; CADET-DANIEL, V et al.The International journal of tuberculosis and lung disease. 2012, Vol 16, Num 2, pp 221-223, issn 1027-3719, 3 p.Article

Hepatotoxicity of Pyrazinamide : Cohort and Case-Control AnalysesCHANG, Kwok C; LEUNG, Chi C; YEW, Wing W et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 12, pp 1391-1396, issn 1073-449X, 6 p.Article

Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugsCOLEMAN, David; WADDELL, Simon J; MITCHISON, Denis A et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 1, pp 146-150, issn 0305-7453, 5 p.Article

Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing StrategyBAUGHN, Anthony D; JIAOYU DENG; VILCHEZE, Catherine et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5323-5328, issn 0066-4804, 6 p.Article

A Novel Mechanism Underlies the Hepatotoxicity of PyrazinamideSHIH, Tung-Yuan; PAI, Chien-Yi; PING YANG et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 4, pp 1685-1690, issn 0066-4804, 6 p.Article

Highly sensitive and selective determination of pyrazinamide at poly-L-methionine/reduced graphene oxide modified electrode by differential pulse voltammetry in human blood plasma and urine samplesCHEEMALAPATI, Srikanth; DEVADAS, Balamurugan; CHEN, Shen-Ming et al.Journal of colloid and interface science. 2014, Num 418, pp 132-139, issn 0021-9797, 8 p.Article

Identification and characterization of Serratia marcescens ZJB-09104, a nitrile-converting bacteriumJIN, Li-Qun; LIU, Zhi-Qiang; ZHENG, Yu-Guo et al.World journal of microbiology & biotechnology. 2010, Vol 26, Num 5, pp 817-823, issn 0959-3993, 7 p.Article

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patientsWILKINS, Justin J; LANGDON, Grant; MCILLERON, Helen et al.European journal of clinical pharmacology. 2006, Vol 62, Num 9, pp 727-735, issn 0031-6970, 9 p.Article

Estimation of antitubercular drugs combination in pharmaceutical formulations using multivariate calibrationMADAN, Jitender; DWIVEDI, A. K; SINGH, S et al.Analytica chimica acta. 2005, Vol 538, Num 1-2, pp 345-353, issn 0003-2670, 9 p.Article

Un effet immuno-allergique rare et grave du traitement antituberculeux: la neutropénie au pyrazinamide = Pyrazinamide-induced neutropenia: One new caseMOUBACHIR, H; ID AHMED, I; BOURKADI, J. E et al.Revue française d'allergologie (Amsterdam. Print). 2013, Vol 53, Num 6, pp 533-536, issn 1877-0312, 4 p.Article

Un effet indésirable grave du traitement antituberculeux : la thrombopénie au pyrazinamide = A severe side effects of antitubercular therapy : pyrazinamide induced thrombocytopeniaROSEAU, J.-B; BERARD, H; N'GUYEN HUY THUY, G et al.Revue des maladies respiratoires. 2008, Vol 25, Num 9, pp 1142-1144, issn 0761-8425, 3 p.Article

Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosisEL-RIDY, M. S; MOSTAFA, D. M; SHEHAB, A et al.International journal of pharmaceutics. 2007, Vol 330, Num 1-2, pp 82-88, issn 0378-5173, 7 p.Article

Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levelsAGRAWAL, Shrutidevi; SINGH, Inderjit; KANWAL JIT KAUR et al.International journal of pharmaceutics. 2004, Vol 276, Num 1-2, pp 41-49, issn 0378-5173, 9 p.Article

Pyrazinamide-Induced Anaphylaxis: Diagnosed by Skin Test and Successful DesensitizationBAVBEK, Sevim; YILIMAZ, Insu; AYDIN, Ömür et al.International archives of allergy and immunology. 2012, Vol 157, Num 2, pp 209-212, issn 1018-2438, 4 p.Article

Molecularly imprinted polymer for pyrazinamideBAO WEI SUN; YUAN ZONG LI; WEN BAO CHANG et al.Analytical letters. 2003, Vol 36, Num 8, pp 1501-1509, issn 0003-2719, 9 p.Article

Epigenetic changes in the rat livers induced by pyrazinamide treatmentKOVALENKO, V. M; BAGNYUKOVA, T. V; SERGIENKO, O. V et al.Toxicology and applied pharmacology. 2007, Vol 225, Num 3, pp 293-299, issn 0041-008X, 7 p.Article

Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB systemKONTOS, Fanourios; NICOLAOU, Stavroula; TSELENTIS, Ioannis et al.Journal of microbiological methods. 2003, Vol 55, Num 1, pp 331-333, issn 0167-7012, 3 p.Article

Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamidePEIHUA GU; CONSTANTINO, Luis; YING ZHANG et al.Journal of medical microbiology. 2008, Vol 57, Num 9, pp 1129-1134, issn 0022-2615, 6 p.Article

PYRAZINAMIDE PLASMA CONCENTRATIONS IN YOUNG CHILDREN WITH TUBERCULOSISMCILLERON, Helen; WILLEMSE, Marianne; SIMON SCHAAF, Hendrik et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 3, pp 262-265, issn 0891-3668, 4 p.Article

Weekly rifapentine/lsoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contactsSCHECHTER, Mauro; ZAJDENVERG, Roberto; FALCO, Gisely et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 8, pp 922-926, issn 1073-449X, 5 p.Article

  • Page / 23